ACADIA Pharmaceuticals Inc.
MX ˙ BMV ˙ US0042251084
SecurityMX:ACAD / ACADIA Pharmaceuticals Inc.
InstitutionPrudential Financial Inc
Latest Disclosed Ownership387,650 shares
Latest Disclosed Value $ 8,629,089
Prudential Financial Inc reports 20.22% decrease in ownership of ACAD / ACADIA Pharmaceuticals Inc.

On May 13, 2026 - Prudential Financial Inc filed a 13F-HR form disclosing ownership of 387,650 shares of ACADIA Pharmaceuticals Inc. (MX:ACAD) valued at $8,629,089 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 485,880 shares of ACADIA Pharmaceuticals Inc.. This represents a change in shares of -20.22% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 387,650 -98,230 -20.22 8,629 -33.51 0.0060
2026-02-13 2025-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 485,880 -423,540 -46.57 12,978 -33.13 0.0157
2025-11-13 2025-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 909,420 223,943 32.67 19,407 31.26 0.0231
2025-08-12 2025-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 685,477 330,876 93.31 14,786 151.06 0.0191
2025-05-13 2025-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 354,601 100,640 39.63 5,890 26.37 0.0084
2025-02-11 2024-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 253,961 253,961 4,660 0.0064
2024-11-14 2024-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -35,811 -100.00 0 -100.00
2024-08-13 2024-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 35,811 -1,036,920 -96.66 582 -97.07 0.0009
2024-05-14 2024-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 1,072,731 629,615 142.09 19,835 42.97 0.0279
2024-02-13 2023-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 443,116 115,500 35.25 13,874 103.21 0.0210
2023-11-13 2023-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 327,616 168,190 105.50 6,828 78.81 0.0107
2023-08-11 2023-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 159,426 119,200 296.33 3,818 404.36 0.0056
2023-05-12 2023-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 40,226 40,226 757 0.0012
2023-02-14 2022-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 0 -17,296 -100.00 0 -100.00
2022-11-04 2022-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 17,296 -9,135 -34.56 283 -24.13 0.0005
2022-08-15 2022-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 26,431 2,700 11.38 373 -35.13 0.0006
2022-05-13 2022-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 23,731 13,861 140.44 575 150.00 0.0008
2022-02-14 2021-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 9,870 -590 -5.64 230 32.18 0.0003
2021-11-15 2021-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 10,460 310 3.05 174 -29.84 0.0002
2021-08-16 2021-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 10,150 10,150 248 0.0003
2021-05-12 2021-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 0 -56,075 -100.00 0 -100.00
2021-08-16 2020-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 0053 004225108 56,075 56,075 2,998 0.0050
2021-02-16 2020-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 56,075 56,075 2,998 0.0050
2020-11-16 2020-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 0 -214 -100.00 0 -100.00
2021-08-05 2020-06-30 13F/A-1 ACADIA PHARMACEUTICALS COM 0048 004225108 214 55 34.59 10 42.86 0.0019
2020-08-12 2020-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 123,140 122,981 5,969 0.0115
2021-08-05 2020-03-31 13F/A-1 ACADIA PHARMACEUTICALS COM 0042 004225108 159 1 0.63 7 0.00 0.0018
2020-05-12 2020-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 299,632 299,474 12,659 0.0280
2021-08-05 2019-12-31 13F/A-1 ACADIA PHARMACEUTICALS COM 0042 004225108 158 0 0.00 7 16.67 0.0018
2020-02-11 2019-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 407,763 407,605 17,444 0.0258
2021-08-05 2019-09-30 13F/A-1 ACADIA PHARMACEUTICALS COM 0035 004225108 158 -214,646 -99.93 6 -99.90 0.0020
2019-11-13 2019-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 394,024 179,220 14,181 0.0225
2019-08-08 2019-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 214,804 167,730 356.31 5,741 354.19 0.0089
2019-05-15 2019-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 47,074 34,625 278.13 1,264 528.86 0.0021
2019-02-07 2018-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 12,449 949 8.25 201 -15.90 0.0004
2018-11-07 2018-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 11,500 -140 -1.20 239 34.27 0.0004
2018-08-13 2018-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 11,640 -111,920 -90.58 178 -93.59 0.0003
2018-05-04 2018-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 123,560 -110,700 -47.26 2,776 -61.96 0.0042
2018-02-13 2017-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 234,260 59,799 34.28 7,298 11.05 0.0099
2017-11-30 2017-09-30 13F/A-1 ACADIA PHARMACEUTICALS COM 004225108 174,461 -9,999 -5.42 6,572 27.74 0.0717
2017-08-07 2017-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 184,460 13,400 7.83 5,145 -12.51 0.0077
2017-05-10 2017-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 171,060 -27,670 -13.92 5,881 2.60 0.0092
2017-02-07 2016-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 198,730 190,272 2,249.61 5,732 2,030.86 0.0092
2016-11-04 2016-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 8,458 400 4.96 269 2.67 0.0004
2016-08-09 2016-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 8,058 428 5.61 262 23.00 0.0004
2016-05-09 2016-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 7,630 300 4.09 213 -18.39 0.0004
2016-02-12 2015-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 7,330 -420 -5.42 261 1.95 0.0005
2015-11-10 2015-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 7,750 100 1.31 256 -20.00 0.0005
2015-08-06 2015-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 7,650 -100 -1.29 320 26.48 0.0006
2015-05-01 2015-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 7,750 0 0.00 253 2.85 0.0004
2015-02-06 2014-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 7,750 -700 -8.28 246 17.70 0.0004
2014-11-12 2014-09-30 13F ACADIA PHARMACEUTICALS COM 004225108 8,450 -8,200 -49.25 209 -44.41 0.0004
2014-08-13 2014-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 16,650 8,200 97.04 376 82.52 0.0007
2014-05-14 2014-03-31 13F ACADIA PHARMACEUTICALS COM 004225108 8,450 300 3.68 206 0.98 0.0004
2014-02-11 2013-12-31 13F ACADIA PHARMACEUTICALS COM 004225108 8,150 -9,396 -53.55 204 -35.85 0.0004
2013-08-07 2013-06-30 13F ACADIA PHARMACEUTICALS COM 004225108 17,546 17,546 318 0.0007
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.